Medication · GLP-1

Semaglutide

Semaglutide is a GLP-1 receptor agonist marketed as Ozempic (diabetes) and Wegovy (weight loss). Available via telehealth in brand and compounded forms.

A licensed clinician determines eligibility and appropriate treatment. Specific medications are not guaranteed.

All verified providers

Providers offering this type of care

Affiliate disclosure: Some providers compensate Telehealth Guide when readers use our links. Partnerships may influence which providers receive featured placement, but they do not change the factual service information we publish. Learn more.

Form Health

Physician-led obesity medicine

Accepts Insurance Messaging / Asynchronous Care
Prescription
Yes
States served
50

Found Health

Clinician-guided medical weight management with GLP-1 pathways

Messaging / Asynchronous Care Same-Day Visits
Prescription
Yes
States served
50

Hers

Women's telehealth for skin, hair, mental, weight

Accepts Insurance Messaging / Asynchronous Care
Prescription
Yes
States served
50

LifeMD

Multi-service telehealth membership

Accepts Insurance Messaging / Asynchronous Care
Prescription
Yes
States served
50

Midi Health

Perimenopause & menopause, insurance

Accepts Insurance Pay Per Visit
Prescription
Yes
States served
50

Oak Weight Loss Program

Online medical weight management with clinician-led assessments

Messaging / Asynchronous Care Available in All 50 States
Prescription
Yes
States served
50

PlushCare

Board-certified physicians, insurance accepted

Accepts Insurance Pay Per Visit
Prescription
Yes
States served
50

WeightWatchers

Weight management and online care

Accepts Insurance Messaging / Asynchronous Care
Prescription
Yes
States served
50

Wisp

Women's sexual and reproductive health telehealth

Messaging / Asynchronous Care Same-Day Visits
Prescription
Yes
States served
50

Want help narrowing the choices?

Answer a few questions to filter these providers based on your preferences.

FAQs

Frequently asked questions

How we researched this pageInformation checked 2026-02-01Reviewed by Dr. Sarah Chen, MDSources: provider sites, state medical boards, FDAEditorial methodology →
Knowledge graph

Explore what connects

Related treatments
Related conditions